L1 (protein)
Top View
- L1 (CD171) Is Highly Expressed in Gastrointestinal Stromal Tumors
- Analysis of the Sequences of the L1 and L2 Capsid Proteins of Papillomaviruses
- CD44 Promotes PD-L1 Expression and Its Tumor
- IFN-Γ Surmounts PD-L1/PD1 Inhibition to CAR-T Cell Therapy by Upregulating ICAM-1 on Tumor Cells
- Integrin Αvβ8–Expressing Tumor Cells Evade Host Immunity by Regulating TGF-Β Activation in Immune Cells
- DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy
- TIGIT/CD226 Axis Regulates Anti-Tumor Immunity
- Poliovirus Receptor (PVR)-Like Protein Cosignaling Network: New
- L1CAM–Integrin Interaction Induces Constitutive NF-Κb Activation In
- CD155 Immunoregulation As a Target for Natural Killer Cell Immunotherapy in Glioblastoma Kyle B
- The Neural Cell Adhesion Molecule L1 Potentiates Integrin- Dependent Cell Migration to Extracellular Matrix Proteins
- Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models
- CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung
- Anti–PD-1/Anti–CTLA-4 Efficacy in Melanoma Brain Metastases Depends on Extracranial Disease and + Augmentation of CD8 T Cell Trafficking
- Recombinant Human Siglec-2/CD22 Protein
- CD44, a Marker of Cancer Stem Cells, Is Positively Correlated with PD-L1
- AACR 2020 HMGA2 Poster V5.1
- A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors